Följ
J. Matthew Meinig
J. Matthew Meinig
USAMRIID
Verifierad e-postadress på health.mil
Titel
Citeras av
Citeras av
År
Synthesis of fluorophores that target small molecules to the endoplasmic reticulum of living mammalian cells
JM Meinig, L Fu, BR Peterson
Angewandte Chemie 127 (33), 9832-9835, 2015
672015
Sobetirome prodrug esters with enhanced blood–brain barrier permeability
AT Placzek, SJ Ferrara, MD Hartley, HS Sanford-Crane, JM Meinig, ...
Bioorganic & medicinal chemistry 24 (22), 5842-5854, 2016
402016
Ester-to-amide rearrangement of ethanolamine-derived prodrugs of sobetirome with increased blood-brain barrier penetration
SJ Ferrara, JM Meinig, AT Placzek, T Banerji, P McTigue, MD Hartley, ...
Bioorganic & medicinal chemistry 25 (10), 2743-2753, 2017
332017
Targeting fatty-acid amide hydrolase with prodrugs for CNS-selective therapy
JM Meinig, SJ Ferrara, T Banerji, T Banerji, HS Sanford-Crane, ...
ACS chemical neuroscience 8 (11), 2468-2476, 2017
322017
Anticancer/antiviral agent Akt inhibitor-IV massively accumulates in mitochondria and potently disrupts cellular bioenergetics
JM Meinig, BR Peterson
ACS chemical biology 10 (2), 570-576, 2014
122014
Structure-Activity Relationships of Central Nervous System Penetration by Fatty Acid Amide Hydrolase (FAAH)-Targeted Thyromimetic Prodrugs
JM Meinig, SJ Ferrara, T Banerji, T Banerji, HS Sanford-Crane, ...
ACS Medicinal Chemistry Letters 10 (1), 111-116, 2019
92019
Derivatives of sobetirome
TS Scanlan, A Placzek, T Banerji, S Ferrara, JM Meinig
US Patent 9,701,650, 2017
72017
Derivatives of sobetirome
TS Scanlan, A Placzek, T Banerji, S Ferrara, JM Meinig
US Patent App. 15/615,408, 2018
52018
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–8